The purpose of this study is to determine if the new medication can prevent symptomatic respiratory illness in patients 65 and over.
20 weeks with 8 office visits; compensation of $450.
Physical Exam, heart & respiratory rate, ECG, blood work, labs, urinalysis.
- Male or females 65
- Patients who require no or minimal assistance with self-care and daily activities
- Patient who are non-smokers -or- quit smoking 1 year prior to screening
- No presence of any other clinically significant lung disease
- Special focus on patients with asthma, heart failure, 85 and older